Variability and phylogeny of the L1 capsid protein gene of human papillomavirus type 5: Contribution of clusters of nonsynonymous mutations and of a 30-nucleotide duplication

Virology

Volumn 221, Issue 1, 1996, Pages 189-198

  Kawase, Masaaki ^a   Orth, Gerard ^a   Jablonska, Stefania ^b   Blanchet Bardon, Claudine ^c   Rueda, Luis Alfredo ^d   Favre, Michel ^a  

^a INSTITUT PASTEUR   (France)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c SAINT LOUIS HOSPITAL   (France)

^d Centro Dermatologico F Lleras A   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS DNA;

AFRICA; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; DNA SEQUENCE; EPIDERMODYSPLASIA VERRUCIFORMIS; EUROPE; GENE DUPLICATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; UNITED STATES; VIRUS ISOLATION; WART VIRUS;

EID: 0030198888     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0365     Document Type: Article

References (52)

1. Bernard, H. U., Chan, S.-Y., and Delius, H. (1994). Evolution of papillomaviruses. Curr. Top. Microbiol. Immunol. 186, 33-54.
2. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Pontén, J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88, 10124-10128.
3. Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., and Lowy, D. R. (1995). Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69, 3959-3963.
4. Chan, S.-Y., Ho, L., Ong, C.-K., Chow, V., Drescher, B., Dürst, M., ter Meulen, J., Villa, L., Luande, J., Mgaya, H. N., and Bernard, H.-U. (1992). Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66, 2057-2066.
5. Chan, S.-Y., Delius, H., Halpern, A. L., and Bernard, H.-U. (1995). Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J. Virol. 69, 3074-3083.
6. Cheng, G., Icenogle, J. P., Kirnbauer, R., Hubbert, N. L., StLouis, M. E., Han, C. L., Svare, E. I., Kjaer, S. K., Lowy, D. R., and Schiller, J. T. (1995). Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172, 1584-1587.
7. Christensen, N. D., Kreider, J. W., Shah, K. V., and Rando, R. F. (1992). Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J. Gen. Virol. 73, 1261-1267.
8. Deau, M.-C., Favre, M., and Orth, G. (1991). Genetic heterogeneity among human papillomaviruses (HPVs) associated with epidermodysplasia verruciformis: Evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 184, 492-503.
9. Deau, M.-C., Favre, M., Jablonska, S., Rueda, L.-A., and Orth, G. (1993). Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J. Clin. Microbiol. 31, 2918-2926.
10. de Villiers, E.-M. (1994). Human pathogenic papillomavirus types: An update. Curr. Top. Microbiol. Immunol. 186, 1-12.
11. Dillner, J., Wiklund, F., Lenner, P., Eklund, C., Fredriksson-Shanazarian, V., Schiller, J. T., Hibma, M., Hallmans, G., and Stendahl, U. (1995). Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int. J. Cancer 60, 377-382.
12. Ellis, J. R. M., Keating, P. J., Baird, J., Hounsell, E. F., Renouf, D. V., Rowe, M., Hopkins, D., Duggan-Keen, M. F., Bartholomew, J. S., Young, L. S., and Stern, P. L. (1995). The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Med. 1, 464-470.
13. Felsenstein, J. (1988). Phylogenies from molecular sequences: Inference and reliability. Annu. Rev. Genet. 22, 521-565.
14. Galloway, D. A. (1994). Human papillomavirus vaccines: A warty problem. Infect. Agent Dis. 3, 187-193.
15. Guilhou, J.-J., Malbos, S., Barnéon, S., Habib, A., Baldet, P., and Meynadier, J. (1980). Epidermodysplasie verruciforme (2 observations): Etude immunologique. Ann. Dermatol. Venereol. 107, 611-619.
16. Higgins, D. G., Bleasby, A. J., and Fuchs, R. (1992). CLUSTAL V: Improved software for multiple sequence alignment. CABIOS 8, 189-191.
17. Ho, L., Chan, S. Y., Burk, R. D., Das, B. C., Fujinaga, K., Icenogle, J. P., Kahn, T., Kiviat, N., Lancaster, W., Mavromara-Nazos, P., Labropoulou, V., Mitrani-Rosenbaum, S., Norrild, B., Pillai, M. R., Stoerker, J., Syrjänen, K., Syrjänen, S., Tay, S. K., Villa, L. L., Wheeler, C. M., Williamson, A. L., and Bernard, H. U. (1993). The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67, 6413-6423.
18. Icenogle, J. P., Sathya, P., Miller, D. L., Tucker, R. A., and Rawls, W. E. (1991). Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 184, 101-107.
19. Icenogle, J. P., Clancy, K. A., and Lin, S. Y. (1995). Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31. Virology 214, 664-669.
20. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Dürst, M., Gissmann, L., Lowy, D. R., and Schiller, J. T. (1993). Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67, 6929-6936.
21. Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R., and Schiller, J. T. (1994). A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. 86, 494-499.
22. Kiyono, T., Adachi, A., and Ishibashi, M. (1990). Genome organization and taxonomic position of human papillomavirus type 47 inferred from its DNA sequence. Virology 177, 401-405.
23. Kremsdorf, D., Favre, M., Jablonska, S., Obalek, S., Rueda, A. L., Lutzner, M. A., Blanchet-Bardon, C., Van Voorst Vader, P. C., and Orth, G. (1984). Molecular cloning and biochemical characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J. Virol. 52, 1013-1018.
24. Kremsdorf, D., Jablonska, S., Favre, M., and Orth, G. (1982). Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis. J. Virol. 43, 436-447.
25. Lin, Y.-L., Borenstein, L. A., Selvakumar, R., Ahmed, R., and Wettstein, F. O. (1992). Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Virology 187, 612-619.
26. Longuet, M., Beaudenon, S., and Orth, G. (1996). Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J. Clin. Microbiol. 34, 738-744.
27. Lutzner, M., Blanchet-Bardon, C., and Orth, G. (1984). Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J. Invest. Dermatol. 83, 18s-25s.
28. Majewski, S., and Jablonska, S. (1995). Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch. Dermatol. 131, 1312-1318.
29. Myers, G., Delius, H., Icenogle, J., Bernard, H.-U., Baker, C., Halpern, A., and Wheeler, C. (1995). L1 protein alignments. In "Human Papillomaviruses 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences," Part II, pp. II.L1.2-II.L1.20. Los Alamos Natl. Lab., Los Alamos, NM.
30. Ong, C. K., Chan, S. Y., Campo, M. S., Fujinaga, K., Mavromara-Nazos, P., Labropoulou, V., Pfister, H., Tay, S.-K., ter Meulen, J., Villa, L. L., and Bernard, H.-U. (1993). Evolution of human papillomavirus type-18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67, 6424-6431.
31. Orth, G. (1987). Epidermodysplasia verruciformis. In "The Papillomaviruses" (P. M. Howley and N. P. Salzman, Eds.), Vol. 2, pp. 199-243. Plenum, New York.
32. Orth, G. (1994). Human papillomaviruses: general features. In "Encyclopedia of Virology" (R. G. Webster and A. Granhoff, Eds.), Vol. 2, pp. 1013-1021. Academic Press, London.
33. Orth, G., Jablonska, S., Jarzabek-Chorzelska, M., Rzesa, G., Obalek, S., Favre, M., and Croissant, O. (1979). Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39, 1074-1082.
34. Pushko, P., Sasagawa, T., Cuzick, J., and Crawford, L. (1994). Sequence variation in the capsid protein genes of human papillomavirus type 16. J. Gen. Virol. 75, 911-916.
35. Risler, J. L., Delorme, M. O., Delacroix, H., and Henaut, A. (1988). Amino acid substitutions in structurally related proteins: A pattern recognition approach. Determination of a new and efficient scoring matrix. J. Mol. Biol. 204, 1019-1029.
36. Roden, R. B. S., Weissinger, E. M., Henderson, D. W., Booy, F., Kirnbauer, R, Mushinski, J. F., Lowy, D. R., and Schiller, J. T. (1994). Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J. Virol. 68, 7570-7574.
37. Roth, D. B., Porter, T. N., and Wilson, J. H. (1985). Mechanisms of nonhomologous recombination in mammalian cells. Mol. Cell. Biol. 5, 2599-2607.
38. Rueda, L. A. (1993). Specific cytopathic effects of human papillomavirus in epidermodysplasia verruciformis. In "Dermatology. Progress and Perspectives: The Proceedings of the 18th World Congress of Dermatology" (W. H. C. Burgdorf and S. I. Katz, Eds.), pp. 226-229. Parthenon Pub., New York.
39. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
40. Seedorf, K., Krämmer, G., Dürst, M., Subai, S., and Röwekamp, W. G. (1985). Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
41. Smits, H. L., Traanberg, K. F., Krul, M. R. L., Prussia, P. R., Kuiken, C. L., Jebbink, M. F., Kleyne, J. A. F. W., van den Berg, R. H., Capone, B., Debruyn, A., and ter Schegget, J. (1994). Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados. J. Gen. Virol. 75, 2457-2462.
42. Sneath, P. H. A., and Sokal, R. R. (1973). "Numerical Taxonomy" (W. H. Freeman, Ed.). Freeman, San Francisco.
43. Streisinger, G., Okada, Y., Emrich, J., Newton, J., Tsugita, A., Terzaghi, E., and Inouye, M. (1966). Frameshift mutations and the genetic code. Cold Spring Harbor Symp. Quant. Biol. 33, 77-84.
44. Van Ranst, M. A., Tachezy, R., Delius, H., and Burk, R. D. (1993). Taxonomy of the human papillomaviruses. Papillomavirus Rep. 4, 61-65.
45. Wanpo, H., Ciochon, R., Yumin, G., Larick, R., Qiren, F., Schwarcz, H., Yonge, C., de Vos, J., and Rink, W. (1995). Early Homo and associated artefacts from Asia. Nature 378, 275-278.
46. Wilbur, W. J., and Lipman, D. J. (1983). Rapid similarity searches of nucleic acid and protein data banks. Proc. Natl. Acad. Sci. USA 80, 726-730.
47. Yabe, Y., Sakai, A., Hitsumoto, T., Kato, H., and Ogura, H. (1991). A subtype of human papillomavirus 5 (HPV-5b) and its subgenomic segment amplified in a carcinoma: Nucleotide sequences and genomic organizations. Virology 183, 793-798.
48. Yaegashi, N., Xi, L., Batra, M., and Galloway, D. A. (1993). Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus type 6 and type 16. J. Infect. Dis. 168, 743-747.
49. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C. M., Hildesheim, A., and Jenison, S. A. (1995). Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69, 7743-7753.
50. Zachow, K. R., Ostrow, R. S., and Faras, A. J. (1987). Nucleotide sequence and genome organization of human papillomavirus type 5. Virology 158, 251-254.
51. zur Hausen, H. (1995). Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? Int. J. Cancer 63, 315-316.
52. zur Hausen, H., and de Villiers, E. M. (1994). Human papillomaviruses. Annu. Rev. Microbiol. 48, 427-447.